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Abstract. 
 
Focal adhesions (FAs) are essential struc-
tures for cell adhesion, migration, and morphogenesis.
Integrin-linked kinase (ILK), which is capable of inter-
 
acting with the cytoplasmic domain of 
 
 
 
1 integrin,
seems to be a key component of FAs, but its exact role
in cell–substrate interaction remains to be clariﬁed.
Here, we identiﬁed a novel ILK-binding protein, af-
ﬁxin, that consists of two tandem calponin homology
domains. In CHOcells, afﬁxin and ILK colocalize at
FAs and at the tip of the leading edge, whereas in skele-
tal muscle cells they colocalize at the sarcolemma
where cells attach to the basal lamina, showing a striped
pattern corresponding to cytoplasmic Z-band striation.
When CHO cells are replated on ﬁbronectin, afﬁxin
and ILK but not FA kinase and vinculin concentrate at
the cell surface in blebs during the early stages of cell
spreading, which will grow into membrane rufﬂes on
lamellipodia. Overexpression of the COOH-terminal
region of afﬁxin, which is phosphorylated by ILK in
vitro, blocks cell spreading at the initial stage, presum-
ably by interfering with the formation of FAs and stress
ﬁbers. The coexpression of ILK enhances this effect.
These results provide evidence suggesting that afﬁxin is
involved in integrin–ILK signaling required for the es-
tablishment of cell–substrate adhesion.
Key words: afﬁxin • cell spreading • focal adhesion •
integrin-linked kinase • integrin
 
Introduction
 
Embryogenesis, metamorphosis, and wound healing de-
pend critically on the ability of cells to form specific con-
 
tacts with the extracellular matrix (ECM)
 
1
 
 (Jockusch et
al., 1995). In addition to guaranteeing the mechanical ad-
hesion of cells, these cell–ECM interactions also trigger
signal transduction pathways that lead to cell proliferation,
differentiation, apoptosis, migration, and specific gene ex-
pressions (Hughes and Pfaff, 1998). The contact sites are
 
defined by morphologically discrete structures that mediate
between the intra- and extracellular regions. Focal adhe-
sions (FAs) represent specialized structures observed at
sites of tight juxtaposition between the cell surface and
ECM in many types of cultured cells. Although typical FAs
are only rarely found in organisms, they have been proven
to be an attractive model for the analysis of the architecture
and regulation of cell–ECM contact in general. At these
sites, actin filaments are bound to transmembrane gly-
coproteins, integrins, through a complex of structural
 
“plaque” proteins that include vinculin, talin, and 
 
 
 
-actinin.
In addition to these components, signal transduction mole-
cules such as FA kinase (FAK) and Src are also concen-
trated at FAs (Miyamoto et al., 1995). Indeed, in extremely
integrated cell functions such as cell migration the integrin
signals are activated at FAs by ECM stimulation and trans-
mitted to intracellular components, producing a dynamic
regulation of cytoskeletal organization. Importantly, al-
though sufficiently rigid to provide strong adhesion, FAs
are highly dynamic and can be reversibly assembled and
disassembled in response to both internal and external sig-
nals. For example, the process of cell migration of cultured
fibroblasts consists of (a) extending membrane protrusions
called lamellipodia or filopodia to form initial cell–sub-
strate attachments, (b) de novo formation of initial FAs at
the tip of these membrane protrusions, (c) development of
the mature forms of the FA complex and actin stress fibers
(SFs) through the organization of several cytoskeletal pro-
teins, and (d) disruption of FA complexes at the rear of the
cell and retraction of the tail (Lauffenburger and Horwitz,
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1996). However, how matrix molecules, integrins, cytoskel-
etal molecules, and signaling molecules collaborate to pro-
mote such integrated events remains to be determined.
Integrins, the major transmembrane glycoproteins in
FAs, consist of two different subunits (
 
 
 
 and 
 
 
 
 chains) that
form a heterodimer (Hynes, 1992). Although their extra-
cellular domains together form a ligand-linking site, their
cytoplasmic domains are considered to provide attach-
ment sites for cytoplasmic structural and signaling mole-
cules. So far, to understand the molecular basis of integrin
signaling, many molecules that can bind directly to the cy-
toplasmic tails of integrins have been successfully identi-
fied. One of these is integrin-linked kinase (ILK), which is
a ubiquitously expressed serine–threonine protein kinase
capable of interacting with the integrin 
 
 
 
 cytoplasmic do-
main (Hannigan et al., 1996). Although the first report on
ILK demonstrated that its activity is regulated by cell–
ECM interaction and that it plays a role in cell adhesion,
the multifunctional aspects of this kinase being involved in
signal transduction pathways including insulin and Wnt
signaling were demonstrated in subsequent works (Hanni-
gan et al., 1996; Delcommenne et al., 1998; Novak et al.,
1998). On the other hand, recent studies have suggested
the possibility that ILK is involved in the process of FA
formation: the overexpression of ILK promotes the colo-
calization of 
 
 
 
5
 
 
 
1 integrin and fibronectin with vinculin
(Wu et al., 1998) and ILK colocalizes with 
 
 
 
5
 
 
 
1 integrin
and FAK in FAs (Li et al., 1999). However, the underlying
molecular mechanism by which ILK is involved in the reg-
ulation of FA formation is still unclear.
In this study, we identified a novel calponin homology
(CH) domain–containing protein, affixin, which interacts
specifically with the kinase domain of ILK. Immunocy-
tochemical analyses demonstrate that affixin colocalizes
with ILK at FAs and at the tip of the leading edge. Fur-
thermore, in cells replated on fibronectin-coated cover-
slips affixin shows codistribution with ILK in bleb-like ini-
tial membrane protrusions at a very early stage of cell
spreading. The introduction of the COOH-terminal half of
affixin, which binds ILK and is phosphorylated by ILK in
vitro, inhibits the development of FAs and SFs and blocks
the cell spreading process at a very early stage. Interest-
ingly, when overexpressed in well-spread CHO cells, the
COOH-terminal half of affixin also disrupts preformed
FAs and SFs, but sufficient activity is observed only when
ILK is coexpressed. These results suggest that affixin may
be one of the downstream targets of ILK, which works at a
very early stage of cell–substrate adhesion to allow the for-
mation of FAs and SFs.
 
Materials and Methods
 
Yeast Two-Hybrid Library Screening
 
cDNAs corresponding to full-length human ILK were amplified from a
human bone marrow cDNA library (CLONTECH Laboratories, Inc.) by
PCR. These fragments were subcloned into pAS2-1, and the resultant
ILK–pAS2-1 was used to screen human bone marrow and fetal liver
cDNA libraries (CLONTECH Laboratories, Inc.) in Y190(a) yeast strain.
Cotransformants of the bait and library plasmids were grown for 3–7 d at
30
 
 
 
C on minimum essential plates lacking histidine, tryptophan, leucine,
and uracil and containing 35 mM 3-aminotriazole (Sigma-Aldrich). Posi-
tive colonies were further screened for 
 
 
 
-galactosidase activity according
 
to the manufacturer’s instructions (CLONTECH Laboratories, Inc.).
Y187(a) yeast strain was also used only for 
 
 
 
-galactosidase assay to verify
the two-hybrid interactions. Approximately 1 
 
  
 
10
 
6
 
 and 4 
 
 
 
 10
 
6
 
 clones
were screened, respectively, and seven independent clones positive for
growth on plates lacking histidine and 
 
 
 
-galactosidase activity were identi-
fied. Sequencing analysis revealed that five of these clones contained
cDNA inserts encoding a 570-bp overlapping sequence. Subsequent back-
screening against phage cDNA libraries from NEC and Jurkat cell lines to
obtain the corresponding full cDNA resulted in the identification of sev-
eral affixin cDNAs with the same ORF but containing different 5
 
 
 
 or 3
 
 
 
noncoding regions.
 
Northern Blot Analysis
 
To analyze the tissue distribution of mRNA expression, multiple tissue
Northern blot membrane (CLONTECH Laboratories, Inc.) was probed
with a 
 
32
 
P-labeled human affixin cDNA probe, corresponding to amino
acid residues 206–481 of the l-affixin prepared using a random-primed
DNA labeling kit (Amersham Pharmacia Biotech). The hybridization was
performed according to the manufacturer’s instructions (CLONTECH
Laboratories, Inc.), and an x-ray film was exposed at 
 
 
 
80
 
 
 
C for 10 d with
an intensifying screen.
 
Affixin and ILK Mutations
 
Affixin and ILK deletion mutants were generated by PCR using appropri-
ate primers. Point mutations in ILK mutants (E359K, K220M, K220A)
were introduced using a QuickChange site-directed mutagenesis kit
(Stratagene). The fidelities of the amplified sequences were all verified by
DNA sequencing.
 
Cell Culture
 
CHO-K1 cells were maintained at 37
 
 
 
C in a humidified atmosphere of 5%
CO
 
2
 
 in F-12 medium containing 10% FCS (Cell Culture Technologies,
Inc.), 100 U/ml penicillin, and 100 
 
 
 
g/ml streptomycin. COS-7 cells were
cultured under the same conditions as those for CHO-K1, except for the
use of DME instead of F-12 medium. cDNA transfection was performed
by either electroporation for the immunoprecipitation assay or lipofection
using a Fugene6 transfection reagent (Roche) for immunofluorescence
analysis. When performing the replating assay, CHO-K1 cells were trans-
fected with the appropriate expression plasmids, harvested 48 h later by in-
cubating in 0.05% trypsin in PBS containing 0.02% (wt/wt) EDTA,
washed two times with PBS, and replated on fibronectin-coated coverslips.
 
Antibodies
 
The antibodies used in this study were anti-Flag and antivinculin mono-
clonal antibodies (Sigma-Aldrich), anti-FAK monoclonal antibodies
(Transduction Laboratories), anti-ILK monoclonal antibody (Upstate
Biotechnology), anti–
 
 
 
-actinin monoclonal antibody (provided by Yukiko
Hayashi, National Institute of Neuroscience, NCNP, Japan), anti-T7 mono-
clonal antibody (Novagen), and FITC-phalloidin and rhodamine-phalloi-
din (Molecular Probes). Antiaffixin antibodies were generated in rabbits
using glutathione 
 
S
 
-transferase (GST)–ss-affixin as an antigen and affinity
purified with the antigen before use.
 
SDS-PAGE and Immunoblot Analysis
 
For analysis of affixin expression in various rat tissues, each organ was ex-
cised from 10-wk-old Sprague Dawley rats deeply anesthetized with di-
ethyl ether, washed with ice-cold PBS, and frozen immediately in liquid
nitrogen. The tissue blocks were crushed using a Cryo-Press (Diatron)
precooled in liquid nitrogen, and the resultant powder was suspended in
10 vol (vol/wt) of SDS sample buffer, homogenized with a Polytron ho-
mogenizer (Kinematica), and sonicated. 15-
 
 
 
g aliquots of these samples
were loaded in each lane. Electrophoresis was carried out by one-dimen-
sional SDS-PAGE (10 or 12% polyacrylamide). The separated proteins
were transferred onto PVDF membranes, which were subsequently
blocked with 5% skimmed milk. The membranes were treated with appro-
priate antibodies, and antibody reactions were visualized by a chemilumi-
nescence ECL system (Amersham Pharmacia Biotech). 
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Immunoprecipitation Assay
 
Cells cultured in 10-cm dishes were suspended in 200 
 
 
 
l lysis buffer con-
taining 20 mM Hepes, pH 7.5, 150 mM NaCl, 1 mM EDTA, 10 
 
 
 
g/ml leu-
peptin, 1 mM PMSF, 1% Triton X-100, 0.1% deoxycholate, and 0.1%
SDS. After a 30-min incubation on ice, the lysates were clarified by cen-
trifugation at 14,000 rpm for 30 min. 15 
 
 
 
l of protein G–Sepharose (Amer-
sham Pharmacia Biotech) conjugated with 2 
 
 
 
g of affinity-purified antiaf-
fixin, anti-Flag antibodies, or control normal rabbit IgG were incubated
with the cell lysates for 1 h at 4
 
 
 
C. After washing with lysis buffer, the im-
munocomplex was solubilized by adding SDS sample buffer to the resin.
 
Immunofluorescence Microscopy
 
CHO-K1 cells or those transfected with expression plasmids were cul-
tured on fibronectin-coated coverslips for 48 h and, after washing with
PBS, fixed with 1 or 2% formaldehyde in PBS for 15 min and then perme-
abilized with 0.1% Triton X-100 in PBS for 15 min at room temperature.
In some experiments, cells were fixed with 100% methanol. The cells were
blocked with PBS containing 10% calf serum for 1 h at room temperature
and then treated with appropriate primary antibodies for 45 min at 37
 
 
 
C in
a moist chamber. After washing with PBS containing 0.05% Tween 20, the
cells were incubated with secondary antibodies (Cy3-conjugated goat
anti–rabbit [Amersham Pharmacia Biotech] and Alexa488-conjugated
goat anti–mouse antibodies [Molecular Probes]) at 37
 
 
 
C for 45 min. After
washing, samples were observed under a fluorescence microscope (BX50;
Olympus) equipped with a cooled CCD camera (Photometrics). Human
skeletal muscle sample was obtained by biopsy for diagnostic purpose
with informed consent. Thin sections of 6-
 
 
 
m thickness were fixed for 10
min with 100% acetone at 
 
 
 
20
 
 
 
C, blocked for 15 min at 37
 
 
 
C with 2%
BSA and 0.5% goat serum in PBS, and then processed for immunofluo-
rescence analysis. Confocal microscopic analysis was performed using a
Bio-Rad Laboratories Radiance 2000 scan head mounted on a Nikon
Eclipse E600 microscope.
 
Purification of Recombinant Affixin and Its 
Mutant from Escherichia Coli
 
GST–ss-affixin and GST–RP2 fusion proteins were induced in 
 
E. coli
 
 with
isopropyl 
 
 
 
-
 
D
 
-thio-galactopyranoside (Amersham Pharmacia Biotech),
and the proteins were purified with glutathione–Sepharose 4B beads
(Amersham Pharmacia Biotech). The GST linker sites of these fusion
proteins were digested with PreScission™ protease (Amersham Pharma-
cia Biotech) according to the manufacturer’s protocol, and the excised re-
combinant proteins eluted from the resin were dialyzed against the appro-
priate buffers before use.
 
In Vitro Kinase Assay
 
COS-7 cells transfected with expression vectors encoding Flag-tagged ILK
or its mutants were lysed in 20 mM Hepes, pH 7.0, 150 mM NaCl, 1 mM
EDTA, 10 
 
 
 
g/ml leupeptin, 1 mM PMSF, 1% Triton X-100, and 0.1%
deoxycholate. Immunoprecipitates by anti-Flag antibody were extensively
washed with lysis buffer and then kinase reaction buffer (50 mM Hepes,
pH 7.0, 10 mM MnCl
 
2
 
, 10 mM MgCl
 
2
 
, 2 mM NaF, 1 mM Na
 
3
 
VO
 
4
 
) and
subjected to protein kinase assays in 20 
 
 
 
l kinase reaction buffer contain-
ing 10 
 
 
 
Ci [
 
 
 
-
 
32
 
P]ATP and an appropriate substrate (myelin basic protein
[MBP] or recombinant affixin). After incubation for 60 min at 30
 
 
 
C, the
reaction mixture was resolved by 10% SDS-PAGE, and bands were visu-
alized by a Bio-imaging analyzer system (BAS2000; Fuji).
 
Results
 
Cloning of a Novel ILK-binding Protein, Affixin
 
Two-hybrid screening against human bone marrow and fe-
tal liver cDNA libraries using full-length human ILK as
bait resulted in the identification of a cDNA sequence en-
coding a novel protein of 364 amino acids (predicted mo-
lecular mass is 41.71 kD) as the longest ORF (Fig. 1; de-
scribed in Materials and Methods). Another candidate for
initiation codon with the preceding Kozak consensus se-
quence (Fig. 1, arrowhead) predicts a shorter product of
 
350 amino acids (40.13 kD). We named these products l-
and s-affixin, respectively, from the Latin word “affixa,”
meaning fixtures, because they are involved in cell–sub-
strate adhesion (see below). A similarity search revealed
that there are affixin homologues in 
 
Caenorhabditis ele-
gans
 
 and 
 
Drosophila melanogaster
 
 (Fig. 1; see below).
During this analysis, a cDNA clone, CGI-56, containing a
sequence identical to affixin except for the 5
 
 
 
 sequence,
was identified as one of the human genes conserved in 
 
C
 
.
 
elegans
 
 (Lai et al., 2000). The remaining two positive
clones obtained in the two-hybrid screening also encoded
novel proteins containing sequences homologous to the
ILK-binding region (see below) of affixin, suggesting that
affixin comprises a novel protein family (data not shown).
 
Affixin Is a Novel Member of the CH
Domain–containing Protein Family
 
Close inspection of the sequence of affixin revealed an in-
ternal sequence repeat that shows a significant sequence
similarity to the actin-binding regions of several actin
cross-linking proteins, such as 
 
 
 
-spectrin, 
 
 
 
-actinin, and
dystrophin (Fig. 1 and Fig. 2 A). In these actin cross-link-
ing proteins, the sequences are composed of 240 amino
acid residues containing a tandem repeat of two CH do-
mains, followed by an extended rod domain with a coiled
coil structure (spectrin repeats; Fig. 2 B). However, the af-
fixin sequence exhibits several unique features. First, as
shown in Fig. 2 B, most of the affixin molecule corresponds
to only two repeated CH domains with short flanking NH
 
2
 
-
and COOH-terminal sequences and lacks the rod domain.
Second, the two tandem CH domains in actin cross-linking
proteins, CH1 (NH
 
2
 
-terminal) and CH2 (COOH-termi-
nal), show weaker homology to each other in contrast to
their intermolecular homology. On the other hand, both
CH domains of affixin show higher homology to the CH1
domains of actin cross-linking proteins (Fig. 2, A and B).
Third, the homology between actin cross-linking proteins
and affixin is restricted to the NH
 
2
 
-terminal half of the CH
domains. The sequence of the COOH-terminal half of af-
fixin is highly diverged, although the COOH-terminal hy-
drophobic moieties that have been suggested to be impor-
tant for the actin binding of these actin cross-linking
proteins are partially conserved (Fig. 2 A, underline;
Carugo et al., 1997). Additionally, the COOH-terminal re-
gions in the affixin CH domains show divergence from the
consensus residues that are essentially conserved in CH
domain–containing proteins such as calponin (Fig. 2 A, as-
terisks). Interestingly, recent progress in genome projects
has revealed that affixin has counterparts in other species
 
.
C. elegans
 
 T21D12.4 shows 64% overall similarity and 45%
identity, whereas 
 
D. melanogaster
 
 AAF49016 shows 71%
similarity and 58% identity (Fig. 1 and Fig. 2 B). Taken to-
gether, we conclude that affixin is a unique member of the
CH domain–containing proteins, which is well conserved
evolutionary from worms to humans.
 
Affixin Is Highly and Ubiquitously Expressed 
in Muscles and Various Tissues
 
Tissue distribution of affixin was examined by Northern
and Western blot analysis. Predicted affixin transcripts
(1.4 kb) were detected in heart, skeletal muscle, spleen, 
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kidney, liver, small intestine, placenta, lung, and periph-
eral blood leukocyte, with the highest expression in skele-
tal muscle and heart (Fig. 3 A). On the other hand, four
additional larger transcripts (2.8, 3.5, 5.0, and 6.5 kb) were
also observed in several human tissues, especially in skele-
tal muscle. Affinity-purified polyclonal antibodies raised
against the full-length amino acid sequence of ss-affixin
(see below) specifically detected two bands (47.4 and 50.5
kD, respectively) in CHO and NIH3T3 cells, each of
which shows the same migration rate as l- and s-affixin
overexpressed in COS-7 cells (Fig. 3 B, arrows). It should
be noted that the expression vector encoding l-affixin also
induced the expression of a protein with lower molecular
weight corresponding to s-affixin. This may indicate that
 
the identified two initiation codons (Fig. 1) are simulta-
neously active in this construct, although the possibility of
specific proteolysis of l-affixin cannot be formally ex-
cluded. Consistent with Northern blot analysis, affixin is
detected ubiquitously, with higher expression in heart and
skeletal muscle (Fig. 3 C). In the spleen, the antibody also
detected a smaller band strongly showing the same migra-
tion rate as overexpressed ss-affixin, which is considered
to be expressed using a more downstream initiation codon
with the preceding Kozak consensus sequence (Fig. 1, as-
terisk; data not shown). In fact, we have obtained an af-
fixin cDNA species from the T cell lymphoma–derived
Jurkat cell line library with an alternatively spliced 5
 
 
 
sequence in which a stop codon appears in front of the
Figure 1. Predicted amino acid sequence of human
affixin. Predicted amino acid sequence of human
affixin (sequence data available from GenBank/
EMBL/DDBJ under accession no. AB048276) is
aligned with the predicted affixin homologue in C. el-
egans (accession no. T21D12.4) and D. melanogaster
(accession no. AAF49016) based on analysis using
clustal W. Residues similar and identical to those of
affixin are lightly and heavily shaded, respectively.
The second and third alternative initiation methio-
nines are indicated by an arrowhead and an asterisk,
respectively. Two CH domains are underlined. 
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third initiation codon mentioned above. Taken together,
these results suggest that ss-affixin, another affixin iso-
form, is highly expressed and functions in spleen.
 
Analysis of the Interaction between ILK and Affixin
 
Fig. 4 A demonstrates that affixin is coprecipitated with
ILK by antiaffixin antibody from CHO cell extract, indi-
cating the endogenous interaction of these proteins in
vivo.
 
 
 
The following experimental results shown in Fig. 4
further reveal the binding sites on each molecule in detail.
Since the cDNA clones obtained by the first two-hybrid
screening contained overlapping sequences correspond-
ing to 242–364 amino acids of affixin, the ILK-binding site
on affixin was considered to be around the second CH do-
main. The subsequent two-hybrid analysis using a series of
affixin deletion mutants revealed that the amino acid se-
quence 258–364, corresponding to the second CH domain,
is sufficient for ILK binding, whereas mutants (l-AFX
292–364) lacking the NH
 
2
 
-terminal half of the second CH
domain lose ILK-binding activity (Fig. 4 B). This interac-
 
tion was further confirmed by coimmunoprecipitation as-
says performed in COS-7 cells: full-length and an NH
 
2
 
-
terminal–truncated mutant of l-affixin, RP2, were coim-
munoprecipitated with Flag-tagged full-length ILK by
anti-Flag antibody, whereas a COOH-terminal truncated
mutant, RP1, was not (Fig. 4 C). These results indicate
that the second but not the first CH domain is required
and sufficient for the interaction with ILK.
Next, we determined the affixin-binding site on ILK us-
ing a similar approach. Two-hybrid assays revealed that
the COOH-terminal kinase domain but not the preceding
ankyrin repeats or pleckstrin homology domain is neces-
sary and sufficient for the interaction with affixin (data not
shown). Coimmunoprecipitation assays in COS-7 cells, the
results of which are shown in Fig. 4 D, provide further in-
sight into the requirement for the interaction. We con-
structed a Flag-tagged kinase-deficient mutant of ILK
(K220M) by substituting the conserved lysine residue in
the ATP-binding site of the kinase domain with methio-
nine and found that the mutant coimmunoprecipitates
with T7-tagged ss-affixin. Thus, we concluded that the ki-
Figure 2. Affixin is a novel CH domain–
containing protein. (A) Alignment of the two
CH domains of human affixin (NH2-termi-
nal CH and COOH-terminal CH) with the first
CH domains in the actin-binding region of
three human actin cross-linking proteins (spec-
trin  , sequence data available from GenBank/
EMBL/DDBJ under accession no. M96803;
 -actinin, accession no. P12814; dystrophin,
accession no. P11532) and the single CH do-
main of human calponin H1 (accession no.
SWP51911). Residues similar and identical to
those of affixin are lightly and heavily shaded,
respectively. Asterisks at the top indicate the
consensus residues that are essentially con-
served among CH domain–containing proteins
(Carugo et al., 1997). The underlined sequence
indicates the COOH-terminal hydrophobic
residues conserved in the first CH domains of
the actin-linking proteins. (B) Schematic dia-
gram of the overall structure of the predicted
affixin protein. Human affixin comprises two
tandem CH domains, both of which show the
closest similarity to the first CH domain in the
actin-binding site of human  -spectrin. In
contrast to spectrin, affixin is unique in that it
lacks the triple-helical repeats (Sr, spectrin
repeats). A C. elegans homologue of affixin
(accession no. T21D12.4) is also shown at the
bottom. 
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nase activity of ILK is not necessary for this interaction.
However, another ILK mutant, E359K, which has been
suggested to be kinase deficient (Novak et al., 1998; see
below), showed greatly reduced interaction with affixin.
This indicates that the glutamic acid residue located in the
 
activation loop of the kinase domain of ILK is critical for
the interaction.
 
Affixin Is a Direct Substrate for ILK In Vitro
 
Since the kinase domain of ILK is sufficient to associate
with affixin, we next tested whether affixin can be phos-
phorylated by ILK in vitro. In Fig. 5 A, Flag-tagged wild-
type or kinase-deficient ILK was overexpressed in COS-7
cells, and the kinase activity in the anti-Flag antibody im-
munoprecipitates was assayed using MBP as a substrate.
The immunoprecipitates from cells expressing wild-type
ILK showed enhanced kinase activity, whereas those from
ILK (K220A)- and ILK(K220M)-expressing cells showed
the background level of the activity. Surprisingly, the im-
munoprecipitate of ILK(E359K) reproducibly showed ki-
nase activity comparable to wild-type ILK, suggesting that
this mutant is not kinase deficient, although we do not
know the reason for the discrepancy with the previous data
(Novak et al., 1998). When we used recombinant affixin
purified from 
 
E. coli
 
 as a substrate, the wild-type ILK im-
munoprecipitates but not the K220M immunoprecipitates
phosphorylated affixin to the same extent as MBP, sug-
gesting that affixin is a good substrate for ILK in vitro
 
 
 
(Fig.
5 B). Consistent with the results on the narrowed binding
site of the ILK–affixin interaction, the deletion mutant of
affixin, RP2, was also phosphorylated by the ILK immuno-
precipitates to a similar extent (Fig. 5 B). We also exam-
ined the possibility that affixin affects the kinase activity of
ILK, since as shown in Fig. 4 D the activation loop of the
kinase domain of ILK is involved in the interaction with af-
fixin. However, the addition of recombinant affixin to the
ILK immunoprecipitates did not affect 
 
32
 
P incorporation
into MBP (data not shown), suggesting that affixin can be
a substrate but not a regulator of ILK kinase activity.
 
Affixin Colocalizes with ILK at the Focal Contacts of CHO 
Cells and the Sarcolemma of Skeletal Muscle Cells
 
To investigate the physiological significance of the ILK–
affixin interaction, we next examined the cellular localiza-
tion of affixin and ILK in well-spread CHO cells cultured
on fibronectin-coated coverslips. As shown in Fig. 6, af-
fixin localizes at FAs identified by staining with antivincu-
lin and antipaxillin antibody (Fig. 6, A and B; data not
shown). Furthermore, affixin staining is also detected at
the tip of the leading edge, which is negative for vinculin
staining (Fig. 6, A and B, arrowheads). Double staining of
affixin and ILK revealed that these proteins are colocal-
ized at both FAs and at the tip of the leading edge. The
colocalization with ILK was also observed for overex-
pressed RP2 but not for RP1 (data not shown), consistent
with the molecular interaction between ILK and affixin de-
tected in the yeast two-hybrid and immunoprecipitation
assays described above (Fig. 4, B and C). As can be seen in
Fig. 6 A, paraformaldehyde fixation but not methanol fixa-
tion (Fig. 6 C) of cells also revealed filamentous staining of
affixin outside dot-like FA structures, which seems to cor-
respond to actin SFs. Immunostaining of overexpressed
T7-tagged ss-affixin with anti-T7 antibody finally con-
firmed this observation: affixin localizes at FAs (Fig. 6, E
and F, arrowheads), at the leading edge (data not shown)
Figure 3. Expression of affixin mRNA and protein in various
tissues and cell lines. (A) Human multiple Northern blots
(CLONTECH Laboratories, Inc.) on which 2  g of polyA RNAs
isolated from the indicated tissues were probed with an affixin
cDNA fragment (206–481 bp). (B) Western blot analysis of total
lysates of CHO-K1 (lane 4) and NIH3T3 (lane 5) cells probed
with the antiaffixin antibody. In lanes 1–3, total lysates of COS-7
cells transfected with pMe18s vector alone (lane 1), s-affixin (lane
2), and l-affixin (lane3) are loaded. Note that s-affixin is also de-
tected in lysate of cell transfected with an expression vector en-
coding l-affixin. (C) 15  g of various tissue lysates from adult rat
was loaded and analyzed with the antiaffixin antibody as indi-
cated. Note that a strong band with a lower molecular weight was
specifically detected in spleen. The migration rate of this band is
the same as that of ss-affixin that is expressed using the third initi-
ation methionine (data not shown; see Fig. 1). AFX, affixin. 
Yamaji et al. 
 
A Novel ILK-binding Protein, Affixin
 
1257
 
and along actin SFs linking separate FAs (Fig. 6, E–H).
Since affixin is highly expressed in muscle cells, we next ex-
amined the localization of affixin and ILK in skeletal mus-
cle cells. Consistent with the localization of the muscle-spe-
cific integrin 
 
 
 
1 isoform, 
 
 
 
1D, reported to date (Vachon et
al., 1997), immnohistochemical analysis of human skeletal
muscle cells revealed that affixin and ILK colocalize at the
sarcolemma, although affixin but not ILK staining is also
detected in cytoplasm (Fig. 7, A–F). Close inspection of
the sarcolemma staining of these proteins using confocal
microscopy revealed their striated distributions on the
membrane, to which Z-bands identified by 
 
 
 
-actinin–stain-
ing anchor (Fig. 7, G–I, arrowheads). These results indi-
cate that affixin and ILK are concentrated to the region on
the sarcolemma where Z-bands attach, which are the cor-
responding structures of FAs in cultured cells.
 
Affixin and ILK May Be Involved in the Early 
Phase of FA Formation
 
Because the leading edge is a site where the formation and
growth of de novo cell–substrate adhesions actively occur,
the above results on the distribution of affixin and ILK at
the tip of the leading edge suggest the possibility that their
interaction plays a role in the initial phase of FA forma-
tion. This notion was supported by analyzing their local-
ization in reseeded CHO cells that are actively spreading.
When CHO cells are harvested in trypsin/EDTA solution
Figure 4. Detailed analysis of the affixin–ILK interaction. (A) Coimmunoprecipitation of ILK with endogenous affixin. Subconfluent
CHO cells were lysed in immunoprecipitation buffer. Antiaffixin and control IgG immunoprecipitates were subjected to SDS-PAGE fol-
lowed by Western blotting with antiaffixin (top) and ILK (bottom) antibodies. (B) Mapping of the ILK-binding region on affixin molecule
by yeast two-hybrid binding assay. cDNA fragments encoding human l-affixin deletion mutants and full-length ILK were subcloned into
pAS2-1 and pGAD424 vectors, respectively. These vectors were cotransformed into yeast Y187(a), and 5 d later the interactions were ex-
amined by  -galactosidase filter assay. (C) COOH-terminal half of affixin is coimmunoprecipitated with ILK from COS-7 cells. Expres-
sion vectors encoding the T7-tagged ss-affixin (left) or its NH2-terminal (RP1) or COOH-terminal (RP2) half (right) were cotransfected
into COS-7 cells with pME18s-Flag expression vectors with or without a full-length ILK cDNA insert. The immunoprecipitation assay was
performed using anti-Flag antibody, and immunocomplexes were subjected to immunoblot analysis with anti-Flag and anti-T7 antibody.
The asterisk indicates a band corresponding to the IgG light chain. (D) The binding of T7-tagged ss-affixin with Flag-tagged ILK point
mutants was examined by immunoprecipitation assays in COS-7 cells. Immunoprecipitation was performed with anti-Flag monoclonal an-
tibody, whereas Western blot analysis of the immunocomplex was carried out using anti-T7 and anti-Flag antibody. ILK(E359K) and
ILK(K220M) represent point mutants in which glutamate 359 in the activation loop or lysine 220 in the ATP-binding region of the ILK ki-
nase domain is replaced with lysine or methionine, respectively. Note that K220M but not E359 coimmunoprecipitates with affixin. 
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and reseeded on fibronectin-coated coverslips, their cell–
substrate adhesions are gradually restored, and their shape
changes from round to spread within 4 h (Bauer et al.,
1993). During the early stages of this spreading process
(1 h after replating) when the cells attach to the substrate
with a limited central area of round cell body, most cells
transiently develop many spherical out-pouchings of the
plasma membrane, blebs, which are ultimately replaced by
flat ruffles or small lamellipodia. As shown in Fig. 8, A–C,
high concentrations of affixin and ILK are observed in
these blebs during the early stages of cell spreading when
the cells still show irregular dot-like staining of vinculin in
their inner area (Fig. 8 D). Overexpressed affixin and ILK
also show similar distribution in blebs (Fig. 8, G and H).
On the other hand, FAK was not observed in these pe-
ripheral membrane protrusions even when blebs have de-
veloped into more flattened lammelipodia-like structures
(Fig. 8, E and F). Actin filament identified by rhodamine-
phalloidin staining was observed only in restricted num-
bers of blebs (data not shown), but at later stages when
cells have started to spread, short actin bundles started to
appear in the peripheral lamellae from the dot-like struc-
tures at which affixin localizes (Fig. 8, I and J). These re-
sults indicate that affixin and ILK are recruited into na-
scent cell–substrate adhesion structures at a very early
stage of cell spreading faster than FAK and vinculin from
which mature FAs and SFs develop.
Next, to obtain further insight into the roles of affixin
and ILK in the initial phase of cell–substrate adhesion, the
effects of the overexpression of ss-affixin and its mutants,
RP1 and RP2, were investigated in this replate assay of
CHO cells (Fig. 9 A). 1 h after reseeding onto fibronectin-
coated coverslips, 
 
 
 
70% of the cells overexpressing each
affixin construct still displayed a round morphology, al-
though cells expressing RP1 tended to show flatter shape
(Fig. 9, B and C, and Fig. 1 H). On the other hand, 4 h af-
ter cell replating a drastic deleterious effect of RP2 over-
expression on cell spreading was observed: in contrast to
cells overexpressing ss-affixin or RP1, many of which ex-
hibited a well-spread flat shape (round cells are 
 
 
 
40%),
 
 
 
70% of RP2-expressing cells still remained in circular or
oval shape with poor membrane extensions (Fig. 9, B and
C, and Fig. 4 H). Close inspection of the RP2-overexpress-
ing cells revealed that they were arrested and unable to
proceed from the early stage of cell spreading with periph-
eral blebs (Fig. 9 D). In these cells, vinculin weakly local-
ized at inner FA-like structures, whereas filamentous actin
formed a weak cortical ring with a high concentration
within limited numbers of blebs (Fig. 9 D). On the other
hand, cells overexpressing RP1 again looked more actively
spread compared with cells expressing wild-type affixin
(ss-affixin), suggesting that RP1 and RP2 have opposite ef-
fects on the establishment of cell–substrate adhesion (Fig.
9 B and Fig. 4 H).
Interestingly, if the overexpression of the affixin mu-
tants was induced in cells that have already established
well-developed cell–substrate adhesions, the effect of RP2
overexpression would be strongly restricted (Fig. 10). Al-
though the overexpression of neither ss-affixin nor ILK af-
fects cell morphology (data not shown), limited numbers
(10%) of cells expressing RP2 but not RP1 (
 
 3%) show
an aberrant spherical morphology instead of the typical
well-spread shape (Fig. 10 B, arrowheads). In these cells,
FAs and SFs are disrupted, exhibiting similar vinculin and
F-actin staining as observed in reseeded cells (data not
shown; Fig. 9 D). Again, cells expressing RP1 tended to
show an enhanced well-spread shape compared with con-
trol CHO cells. Interestingly, the coexpression of ILK
with RP2 but not kinase-deficient ILK(K220M) or
ILK(E359K), that is kinase active but incompetent to bind
affixin (Figs. 4 and 5), increased the population of aber-
rant round-shaped cells ( 50%; Fig. 10, E and F). This ef-
fect of ILK was not observed in cells expressing RP1 (Fig.
10 C). Therefore, these results indicate that the second CH
domain of affixin requires the interaction with active ILK
to exert the deleterious effects on cell–substrate adhesion,
whereas it does not in cells that are actively spreading (Fig.
9 B compared with Fig. 10, B and D).
Figure 5. ILK phosphorylates affixin in vitro. (A) Kinase activity of wild-type ILK and its point mutants overexpressed in COS-7 cells.
Flag-tagged ILK or its mutants were overexpressed and immunoprecipitated from COS-7 cell lysates with monoclonal anti-Flag antibody.
Kinase activities of the resultant immunocomplexes were examined using MBP as a substrate. Top, autoradiography showing 32P incorpo-
ration into MBP; bottom, Western blot analysis of the precipitated Flag-tagged ILK or its mutants using polyclonal anti-Flag antibody. (B)
Full-length and COOH-terminal half of ss-affixin are phosphorylated by ILK in vitro. Recombinant full-length and COOH-terminal half
of ss-affixin (RP2) were used as substrates to estimate the kinase activity of the ILK immunocomplexes prepared as described in A.Yamaji et al. A Novel ILK-binding Protein, Affixin 1259
Discussion
Affixin, a Novel Component of FAs, Is Recruited 
with ILK into the Nascent Structure Formed 
during the Very Early Stages of Cell Spreading
Here, we report a novel CH domain–containing protein
named affixin as a binding protein for ILK, a serine–threo-
nine protein kinase that interacts with the cytoplasmic re-
gion of  1 integrin. Affixin and ILK associate in vivo and
colocalize at FAs in well-spread cultured cells, suggesting
that affixin is a novel component of FAs that may be in-
volved in integrin–ILK signaling at this specific structure.
Immunofluorescence analysis of cells in the spreading pro-
cess after replating on fibronectin indicates that endoge-
nous and exogenously expressed affixin and ILK accumu-
late in cell surface blebs observed during the very early
phase of the spreading process. These blebs have been
shown to be spherical out-pouchings of the plasma mem-
Figure 6. Colocalization of affixin with ILK at FAs
and the tip of the leading edge in CHO cells. Immu-
nofluorescence staining with antiaffixin antibody of
CHO cells (A and C) or with anti-T7 antibody of
CHO cells transfected with T7-tagged affixin (E and
G). Cells were stained simultaneously with antivin-
culin (B and F), anti-ILK (D) antibodies, or
rhodamine-phalloidin (H). In E–H, CHO cells are
reseeded on fibronectin-coated coverslips and fixed
after 4-h spreading. Note that affixin and ILK are
colocalized at FAs visualized by vinculin staining
(A, B, and E and F, arrowheads) and at the tip of
the leading edge (A–D, arrowheads). In C and D,
fixation was performed with 100% cold methanol,
whereas in other cases 1 (A and B) or 2% (E–H)
paraformaldehyde in PBS was used. Intense signals
from nuclei or perinuclear region represent nonspe-
cific staining of the antiaffixin antibody observed
depending on the fixation conditions. Bar, 25  m.The Journal of Cell Biology, Volume 153, 2001 1260
brane that are commonly observed at the periphery of eu-
karyotic cells as they spread on a substrate or at the leading
edge of moving cells (Bereiter-Hahn et al., 1990). They are
considered to be transient structures that are driven by hy-
drodynamic forces and finally result in other types of pro-
trusions such as membrane ruffles on lamellipodia (Cun-
ningham, 1995). They also correspond to the membrane
ruffles where endogenous  -integrin and another ILK-
binding protein, PINCH, have been shown to concentrate
during cell spreading (Tu et al., 1999). These results suggest
that integrin–ILK signaling plays a role in the early phase
of cell spreading, and affixin and PINCH also participate in
this process. Importantly, vinculin and FAK do not accu-
mulate in these regions at this stage (Fig. 8, D and F), sug-
gesting that ILK and affixin are recruited into these nascent
substrate adhesion sites in advance of these FA compo-
nents. We further demonstrate that during the later stage of
cell spreading, affixin shows punctuate staining at lammeli-
podia from which short actin bundles emanate (Fig. 8, I and
J) and finally colocalizes with vinculin and FAK at FAs
(Fig. 6, A and E; data not shown). In well-spread cells, ILK
and affixin are also detected at the tip of the leading edge of
lammelipodia where formation and growth of de novo cell–
substrate adhesions actively occur. These results strongly
indicate that affixin is involved in integrin–ILK signaling re-
quired for the nascent cell–substrate adhesion structures,
which will develop into mature FAs.
FAs form and disappear continuously during cell loco-
motion and the cell spreading process, and the underlying
molecular basis of this dynamic nature of FAs has been ex-
tensively investigated. FAK, one of the major protein ki-
nases accumulating at FAs, was thought to function in the
initial step of FA formation, partially because many FA
components are tyrosine phosphorylated during the FA
formation. However, recent results revealed that FAs can
be formed even in the absence or inhibition of FAK activ-
Figure 7. Affixin and ILK
localize at the sarcolemma of
skeletal muscle cells. Immu-
nofluorescence analysis of
cross (A) or longitudinal (B
and G) sections of human
skeletal muscle with antiaf-
fixin antibody. Cells were
stained simultaneously with
anti-ILK antibody (B and E)
and anti– -actinin antibody
(H). Merged views are also
demonstrated (C, F, and I).
Observations were per-
formed using confocal mi-
croscopy, and in D–I optical
sections (0.4  m) that tangen-
tially cut off the sarcolemma
were selected to demon-
strate the striped pattern of
affixin and ILK staining on
the sarcolemma. In this sec-
tion, staining of Z-bands with
anti– -actinin almost disap-
pears, but in some regions
the completely matched cor-
relation between affixin
staining and Z-band is clearly
demonstrated. Note that af-
fixin concentrated in the sites
of the sarcolemma where
Z-bands anchor (I, arrow-
heads). Bars, 25  m.Yamaji et al. A Novel ILK-binding Protein, Affixin 1261
ity, implying the presence of more essential signaling mol-
ecules regulating the formation of the FA complex (Ilic et
al., 1995). The recent finding of ILK, which is activated
within 30–45 min after plating on fibronectin (Delcom-
menne et al., 1998) and is localized to FAs in CHO cells
(Li et al., 1999), suggests the new possibility that this
serine–threonine kinase is involved in FA formation. In
this context, the present results are important in not only
supporting these notions about the physiological function
of ILK signaling but also suggesting the involvement of af-
fixin in this ILK function.
Affixin Is a Possible ILK Substrate That Transmits 
Integrin–ILK Signaling for the Initial FA Formation
Yeast two-hybrid assays and immunoprecipitation assays
in COS-7 cells revealed that the kinase domain of ILK in-
teracts specifically with the second CH domain of affixin.
The glutamic acid residue located in the activation loop of
the ILK kinase domain is further demonstrated to be criti-
cal for the interaction. Consistently, in vitro kinase assay
showed that the second CH domain can be a substrate for
ILK, suggesting the possibility that affixin is a novel in vivo
substrate for ILK, which links integrin–ILK signaling to
the initial FA formation. This was further supported by
showing the deleterious effects of an affixin deletion mu-
tant, RP2, corresponding to the second CH domain, on FA
formation: when CHO cells overexpressing RP2 were re-
seeded on fibronectin,  75% of the cells retained their
round form and could not develop FAs and SFs. Closer in-
spection further suggested that the cells were completely
blocked at the initial phase of the spreading process with
many surface blebs. Interestingly, this effect of RP2 on FA
formation was not significantly observed if it was ex-
pressed in cells which have already established FAs. Only
a limited number ( 10%) of cells expressing RP2 alone
showed a round shape, and the number was dramatically
increased to levels comparable to those of spreading cells
when wild-type ILK was cotransfected. Because this en-
hancement was not observed by cotransfection of kinase-
deficient ILK K220M or an affixin-binding–deficient ILK
mutant, ILK(E359K), these results indicate that the effect
of RP2 is dependent on the interaction with active ILK,
probably on the phosphorylation by ILK. The apparent
discrepancy of the effects of RP2 on well-spread cells and
on actively spreading cells can be reasonably explained by
assuming that integrin–ILK signaling evoked by initial
cell–substrate interaction (Delcommenne et al., 1998)
mimics the effect of ILK overexpressing in actively spread-
ing cells. Although further studies will be needed, the
present result about the positive effect of RP1, the first CH
domain, on cell spreading may suggest that this domain is
also involved in the interaction with the downstream target
for FA formation in a different way from RP2.
Amino acid sequence analysis of affixin revealed it to
represent a novel member of the CH domain–containing
protein family that is conserved from worms to mammals.
Considering that most CH domain–containing proteins
have been shown to be related to the actin cytoskeleton
(Stradal et al., 1998), the putative molecular target of af-
fixin may be the actin cytoskeleton. This notion is further
supported by the fact that both CH domains in affixin ex-
Figure 8. Distribution of affixin during the early stages of the
cell spreading process. CHO cells (A, C, and E) or those cotrans-
fected with T7-tagged affixin and Flag-tagged ILK (G and I) were
replated on fibronectin-coated coverslips and 1 h later fixed and
stained with antiaffixin or anti-T7 antibodies as indicated. Cells
were stained simultaneously with anti-ILK (B), antivinculin (D),
anti-FAK (F), anti-Flag (H) antibodies, or FITC-phalloidin (J).
Note that affixin is concentrated in peripheral blebs (A–F, arrow-
heads), whereas in well-spread cells dot-like staining is observed
from which F-actin bundles emanate (I and J). Fixation is 100%
methanol (A–F), 2% paraformaldehyde (G–J). Bars, 25  m.The Journal of Cell Biology, Volume 153, 2001 1262
hibit the closest homology to those of the actin-binding re-
gions of actin cross-linking proteins such as  -spectrin and
 -actinin. Hence, it is quite possible that affixin also binds
directly to F-actin. In fact, we observed that although
weakly, endogenous affixin localizes to SFs in cultured
cells (Fig. 6, A, E, and G). However, despite extensive ef-
forts, we have not succeeded in detecting the direct inter-
actions of affixin or RP2 with F-actin and cannot yet dis-
cuss the molecular mechanism by which affixin plays
critical roles in FA development in detail. It may be due to
the unique divergence of affixin from the sequence of ac-
tin-linking proteins. Of course, it is possible that the phos-
phorylation of affixin by ILK is required for its interaction
with F-actin. We are now conducting further experiments
to address these issues as one of the major extensions of
the present study.
Affixin and ILK in Muscle Cells
Northern and Western blot analyses showed that affixin is
highly expressed in skeletal muscle and heart, suggesting its
role in cell–substrate interaction in muscle cells. Interest-
ingly, the mutation/depletion of the C. elegans homologue
of  -integrin (pat-3) or ILK-binding protein, PINCH (unc-
97), from the embryo was reported to result in a similar
phenotype called “pat” showing paralysis and elongation
arrest at the twofold stage due to defects in the integrity of
myofibril structures in the body wall muscle (Williams and
Waterston, 1994; Gettner et al., 1995; Dedhar et al., 1999;
Hobert et al., 1999). Since the body wall muscles of these
mutants show disorganized dense bodies (structural ana-
logues of FAs in cultured cells) to which  -integrin/PAT-3,
vinculin/DEB-1, and PINCH/UNC-97 are localized, it has
been suggested that defects in the development of dense
bodies are the primary cause of the phenotype (Gettner et
al., 1995; Hobert et al., 1999). Interestingly, we recently
observed that the C. elegans embryo from which the ex-
pression of ILK or affixin homologues (CAB77052 or
T21D12.4, respectively) was deleted by the RNA interfer-
ence method shows pat phenotype characterized by an ar-
rest during its development at twofold stage and paralysis
(Sugiyama, Y., unpublished results). Although we have not
confirmed that these are primarily caused by defects in
muscle attachments, our present results showing ILK and
affixin play important roles in FA development, and it
Figure 9. Overexpression of the affixin dele-
tion mutant, RP2, inhibits the progression of
the cell-spreading process. (A) Western blot
analysis showing relative expression levels of
each construct in CHO-K1 cells. The total ly-
sates of CHO-K1 transfected with indicated
expression vectors were prepared 48 h after
transfection and analyzed using anti-T7 anti-
body. (B) CHO cells transfected with T7-
tagged ss-affixin or its deletion mutants (RP1
or RP2) were replated on fibronectin-coated
coverslips 48 h after transfection. 1 or 4 h
later, the cells were fixed and stained with
anti-T7 polyclonal antibody. (C) The numbers
of transfected cells with round morphology
were counted at 1 and 4 h after replating. As
control, CHO cells treated in a manner similar
to the transfected cells were stained with
rhodamine-phalloidin and counted. Note that
cells transfected with RP2 but not ss-affixin or
RP1 are blocked in the round morphology
even at 4 h after reseeding. The values given
represent mean values (  SD) of three inde-
pendent experiments. (D) Cells overexpress-
ing T7-tagged RP2 were doubly stained with
anti-T7 polyclonal antibody (left) and FITC-
phalloidin or antivinculin monoclonal anti-
body as indicated. Bars, 25  m.Yamaji et al. A Novel ILK-binding Protein, Affixin 1263
might be reasonable to speculate that these embryo also
have defects in dense body formation. Consistently, immu-
nohistochemical analysis of human skeletal muscle demon-
strated that affixin and ILK colocalize to the sarcolemma
showing a striated pattern matching cytoplasmic Z-band
striation, suggesting that these proteins accumulate at sites
where the Z-band attaches to the sarcolemma, which corre-
spond to dense bodies in C. elegans body wall muscle cells.
Taken together, these results imply the possibility that af-
fixin and ILK are also important for muscle development
and function.
During the revision of this manuscript, a novel CH do-
main protein similar to affixin, actopaxin, was reported as
a paxillin-binding protein. One of the clones we obtained
in the two-hybrid screening using ILK as bait, FL29, was
identical to actopaxin, indicating that this protein also
binds ILK. Affixin and actopaxin are products of distinct
genes with different expression patterns but share com-
mon features such as localization to focal contact.
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